From: Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis
Female sex, n (%) | 104 (65.4) |
Age (years), mean ± SD | 57.2 ± 10.9 |
Education, n (%) | Â |
 Low | 37/158 (23.4) |
 Medium | 93/158 (58.9) |
 High | 28/158 (17.7) |
Current smoking (yes), n (%) | 27 (17.0) |
Current alcohol use (yes), n (%) | 120 (75.5) |
Disease duration (years), median (IQR) | 6.0 (3.0–12.0) |
Concomitant FM (yes), n (%) | 23/158 (14.6) |
Prescribed RA medication | Â |
 DMARD | 95 (59.7) |
 DMARD plus biologic | 40 (25.2) |
 Biologic only | 18 (11.3) |
 NSAID only | 5 (3.1) |
 Other painkiller only | 1 (0.6) |
Self-reported current pain medication (yes), n (%) | 81/158 (51.3) |
Self-reported current neuropathic pain medication (yes), n (%) | 9/158 (5.7) |
DAS28 (0–10), mean ± SD | 2.1 ± 1.0 |
ESR (mm/hour), median (IQR) | 8.0 (5.0–17.0) |
CRP (mg/l), median (IQR) | 3.0 (1.0–7.0) |
SJC (0–28), median (IQR) | 0 (0–1) |
TJC (0–28), median (IQR) | 0 (0–1) |
HAQ-DI (0–3), mean ± SD | 0.7 ± 0.6 |
SF-36 PCS (0–100), mean ± SD | 41.7 ± 9.4 |
SF-36 MCS (0–100), mean ± SD | 50.3 ± 10.3 |